Maccura Biotechnology: Announcement regarding the company's new product obtaining a product registration certificate.
Maccura Biotechnology: 300463 MACCURA BIOTECH Investor Relations Management Information 20240802
Maccura Biotechnology: Announcement regarding the progress of repurchasing company shares.
Maccura Biotechnology: Half-year report for the year 2024.
Maccura Biotechnology: Summary Table of Non-Operating Funds Used and Other Related Fund Transactions for the First Half of 2024.
Maccura Biotechnology: Announcement of the resolution of the 16th meeting of the 5th Board of Supervisors.
Maccura Biotechnology: Announcement of the resolution of the 18th meeting of the 5th board of directors.
Maccura Biotechnology: Announcement on disclosure of the 2024 interim report
Maccura Biotechnology: Special report on the use and placement of funds raised during the first half of 2024.
Maccura Biotechnology: Summary of Half-Year Report in 2024.
Maccura Biotechnology: Announcement regarding the company's new product obtaining a product registration certificate.
Maccura Biotechnology: Announcement Regarding the Progress of Guarantees
Maccura Biotechnology: Announcement on the adjustment of the maximum repurchase price after the implementation of the 2023 annual equity distribution.
Maccura Biotechnology: Announcement regarding the progress of repurchasing company shares.
Maccura Biotechnology: Announcement of Annual Equity Distribution Implementation in 2023
Maccura Biotechnology: Announcement regarding the completion of the first registration of the first type of restricted stocks awarded under the restricted stock incentive plan for 2024.
Maccura Biotechnology: Announcement regarding the company's new product obtaining a product registration certificate.
Maccura Biotechnology: Announcement regarding the registration certificate of new products obtained by the wholly-owned subsidiary.
Maccura Biotechnology: Announcement on Progress Made Regarding the Provision of Guarantees by the Company to Its Wholly-Owned Subsidiaries.
Maccura Biotechnology: Announcement on the Progress of Using Part of the Idle Raised Funds for Cash Management
No Data